Medirom Healthcare Technologies (MRM) Invested Capital (2019 - 2024)

Medirom Healthcare Technologies has reported Invested Capital over the past 6 years, most recently at $10.2 million for Q4 2024.

  • Quarterly results put Invested Capital at $10.2 million for Q4 2024, up 147.35% from a year ago — trailing twelve months through Dec 2024 was $10.2 million (up 147.35% YoY), and the annual figure for FY2024 was $10.2 million, up 147.35%.
  • Invested Capital for Q4 2024 was $10.2 million at Medirom Healthcare Technologies, up from $4.1 million in the prior quarter.
  • Over the last five years, Invested Capital for MRM hit a ceiling of $10.2 million in Q4 2024 and a floor of -$405474.3 in Q4 2021.
  • Median Invested Capital over the past 5 years was $4.1 million (2023), compared with a mean of $4.3 million.
  • Biggest five-year swings in Invested Capital: tumbled 105.78% in 2021 and later skyrocketed 1367.35% in 2023.
  • Medirom Healthcare Technologies' Invested Capital stood at $7.0 million in 2020, then plummeted by 105.78% to -$405474.3 in 2021, then soared by 169.46% to $281646.3 in 2022, then skyrocketed by 1367.35% to $4.1 million in 2023, then soared by 147.35% to $10.2 million in 2024.
  • The last three reported values for Invested Capital were $10.2 million (Q4 2024), $4.1 million (Q4 2023), and $281646.3 (Q4 2022) per Business Quant data.